This competitive renewal application addresses the following challenging question in current biology: What are the molecular mechanisms by which related transcription factor isoforms, displaying identical DNA sequence specificity and expressed in the same cell, actually mediate distinct transcriptional responses. The POU-homeodomain transcription factor, Pit-1, controls the development of somatotroph, lactotroph and thyrotroph pituitary cell- types and regulates the cell-specific expression of GH, PRL and TSHbeta genes. The single Pit-1 gene is expressed in the three pituitary cell types as two alternatively-spliced mRNAs, resulting in Pit-1 and Pit- 1beta proteins. Pit-1beta contains a unique 26 amino acid (AA) beta- domain inserted at AA 48 of Pit-1 precisely in the middle of the transcription activation domain (TAD). Initial studies describing Pit- 1beta revealed that the two Pit-1 isoforms bound to the same DNA site with the same relative affinity, yet they displayed promoter selectivity. Although the functional role of Pit-1beta has been largely overlooked by the field, we have discovered the beta-domain imparts unique positive and negative regulatory features to Pit-1beta with regards to PRL promoter activation. Specifically, Pit-1beta inhibited basal and Ras-stimulated rPRL promoter activity in GH4 pituitary cells, yet Pit-1beta reconstituted basal activity and enhanced the PKA response of the rPRL promoter in HeLa non-pituitary cells. We have shown that it the identify the amino acid sequence of the beta-domain, and not just the altered spacing of the TAD generated by the beta-domain insertion, that confers upon Pit-1beta these unique transcriptional properties. Thus, the Pit-1/Pit-1beta pair provides a prototypical model to study transcription factor isoform-specific functions. We hypothesize that Pit-1 isoform specific responses are due to selective protein partnerships dictated by an isoform-specific protein-protein interaction domain(s). Thus, the beta-domain functions as a beta isoform-specific interaction surface, resulting in protein-protein interactions specific to the Pit-1beta isoform. Corollary to this is that proteins that bind to the Pit-1 TAD in the region disrupted by the beta-domain insert site (AA48), may no longer bind to Pit-1beta. To address this hypothesis, we propose five Specific Aims: (1) To determine the precise amino acids of the beta-domain that dictate Pit-1beta specific transcriptional properties; (2) To elucidate whether beta-domain function is dependent upon protein context; (3) To determine the effects of DNA recognition sites upon Pit-1 and Pit-1beta functional relevance of beta-specific protein-protein interactions. Insights gained from these studies will not only provide a better understanding of Pit-1 isoform-specific function, but will also provide a conceptual and experimental framework to study other highly related transcription factors that bind to overlapping DNA sites.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK037667-16
Application #
6624849
Study Section
Endocrinology Study Section (END)
Program Officer
Malozowski, Saul N
Project Start
1986-07-01
Project End
2004-11-30
Budget Start
2002-12-01
Budget End
2004-11-30
Support Year
16
Fiscal Year
2003
Total Cost
$347,019
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Tong, Yunguang; Zhou, Jin; Mizutani, Jun et al. (2011) CEBPD suppresses prolactin expression and prolactinoma cell proliferation. Mol Endocrinol 25:1880-91
Jonsen, Matthew D; Duval, Dawn L; Gutierrez-Hartmann, Arthur (2009) The 26-amino acid ss-motif of the Pit-1ss transcription factor is a dominant and independent repressor domain. Mol Endocrinol 23:1371-84
Jedlicka, Paul; Sui, Xiaomei; Gutierrez-Hartmann, Arthur (2009) The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer 9:197
Jedlicka, Paul; Sui, Xiaomei; Sussel, Lori et al. (2009) Ets transcription factors control epithelial maturation and transit and crypt-villus morphogenesis in the mammalian intestine. Am J Pathol 174:1280-90
Jedlicka, Paul; Gutierrez-Hartmann, Arthur (2008) Ets transcription factors in intestinal morphogenesis, homeostasis and disease. Histol Histopathol 23:1417-24
Ferry, A L; Locasto, D M; Meszaros, L B et al. (2005) Pit-1beta reduces transcription and CREB-binding protein recruitment in a DNA context-dependent manner. J Endocrinol 185:173-85
Farrow, Kathryn N; Bradford, Andrew P; Tentler, John J et al. (2004) Structural and functional analysis of the differential effects of c-Jun and v-Jun on prolactin gene expression. Mol Endocrinol 18:2479-90
Dunkelberg, J C; Gutierrez-Hartmann, A (2001) LZ-FYVE: a novel developmental stage-specific leucine zipper, FYVE-finger protein. DNA Cell Biol 20:403-12
Diamond, S E; Gutierrez-Hartmann, A (2000) The Pit-1beta domain dictates active repression and alteration of histone acetylation of the proximal prolactin promoter. J Biol Chem 275:30977-86
Farrow, K N; Gutierrez-Hartmann, A (1999) Transforming growth factor-beta1 inhibits rat prolactin promoter activity in GH4 neuroendocrine cells. DNA Cell Biol 18:863-73

Showing the most recent 10 out of 35 publications